Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
This is an open label, 2-part early phase study designed to evaluate the safety, pharmacokinetics, radiation dosimetry, and preliminary efficacy of TLX090-Tx in patients with painful bone metastases.
Epistemonikos ID: 33391054955561c53e9e87e1a7d6827f9f750ae5
First added on: Sep 30, 2025